Navigation Links
BRAVE Awards Now Accepting Nominations
Date:4/24/2013

DUBLIN, Ireland, April 24, 2013 /PRNewswire/ --

The BRAVE Awards, an international awards initiative that recognizes the courage and dedication of non-professional caregivers, is accepting nominations for its 2013 program. Now in its third year, the BRAVE Awards honors those unsung everyday heroes - unpaid, non-professional caregivers - who give of themselves every day in a meaningful, dedicated and selfless manner.  

Developed and implemented by Shire plc, the global biopharmaceutical company, the BRAVE Awards is taking nominations now through June 30, 2013. Up to 20 nominees from around the world will be selected as BRAVE Awards recipients and each will be awarded $10,000 USD or the equivalent in local currency.

The nomination process is straightforward: consider a non-professional caregiver you believe deserves recognition; review the official website at http://www.ShireBRAVEAwards.com to learn more; and complete the online nomination form. recipients will be announced in November 2013. A Selection Committee consisting of Shire employees and non-Shire representatives who are experts and advocates in the caregiving field choose the recipients.

"Those nominated for the BRAVE Awards represent the invisible army of millions of family caregivers," said Flemming Ornskov, MD, Chief Executive Designate, Shire. "Their consistent care of others is an enormously generous and selfless commitment.  We are privileged to raise awareness about the significant impact non-professional carers play in our society and to recognize individuals who work tirelessly to give their loved ones as normal and healthy a life as possible."

A caregiver is defined by the Shire BRAVE Awards as an individual who is providing regular, consistent care for another person in a volunteer capacity. The caregiver can be a relative, neighbor, or friend who gives their time, support, and compassion regularly, helping another person who is not able to care for himself or herself. The caregiver cannot be a professional healthcare provider and cannot be compensated in any formal way through their activities as a caregiver.  Doctors, nurses, hospital staff and other healthcare workers are not eligible for consideration; however, they can nominate non-professional caregivers. Nominees must be age 18 or older at the time of nomination. In 2013, the Shire BRAVE Awards are open to eligible nominees in 19 countries - Australia, Belgium, Brazil, Canada, Denmark, Finland, France, Germany, Ireland, Italy, Luxemburg, Netherlands, Norway, Portugal, Spain, Sweden, Switzerland, the United Kingdom and the United States.

There are no restrictions on the type of care being provided, no correlation with any health condition or therapeutic area, and the care recipient need not be prescribed a Shire medicine or treatment. The program has been developed to ensure confidentiality and privacy, and adheres to Shire's Privacy Policy. The BRAVE Awards are presented in the spirit of Shire's BRAVE culture.  

NOTES TO EDITORS

About the Shire BRAVE Awards

The Shire BRAVE Awards is an international program created by Shire to honor the courage and dedication of individual voluntary caregivers.  For the Shire BRAVE Awards, a caregiver is defined as an individual who is providing regular, consistent care for another person(s).  The caregiver cannot be a professional healthcare provider and cannot be compensated in any formal way through their efforts as a caregiver.  The caregiver can be a relative, neighbor, or friend who gives their time, support, and compassion regularly, helping another person(s) who is (partly or wholly) unable to care for themselves due to health and wellness issues, injury, or other extenuating circumstance.  Nominations for the 2013 BRAVE Awards will be accepted through June 30, 2013 and award recipients will be announced in November 2013.  For further information on the Shire BRAVE Awards, including official rules, legal disclosures, and Privacy Policy please visit http://www.ShireBRAVEAwards.com.

Shire enables people with life-altering conditions to lead better lives.

Through our deep understanding of patients' needs, we develop and provide healthcare in the areas of:

  • Behavioral Health and Gastro Intestinal conditions
  • Rare Diseases
  • Regenerative Medicine

as well as other symptomatic conditions treated by specialist physicians.

We aspire to imagine and lead the future of healthcare, creating value for patients, physicians, policymakers, payors and our shareholders.

http://www.shire.com

For further information please contact:

Matthew Cabrey , mcabrey@shire.com , +1-484-595-8248
Bev Volpe , bvolpe@simonpr.com , +1-484-595-9836



'/>"/>
SOURCE Shire plc
Copyright©2012 PR Newswire.
All rights reserved

Related biology technology :

1. Bio-IT World Announces Best of Show Awards Finalists for the Bio-IT World Conference & Expo
2. Elsevier and the Belarus Ministry of Education Honor Researchers with Scopus Awards
3. American Federation for Aging Research Announces Recipients of Irving S. Wright and Vincent Cristofalo Scientific Awards
4. US Radiopharmaceuticals (USR) Awards Contract to Von Gahlen International for New Technetium-99m Generator Production Line Using Low Enriched Uranium Molybdenum-99
5. USP Global Fellowship Awards Program Call for Applications
6. 2012-2013 Michael E. DeBakey Journalism Awards Call for Entries
7. Indigo Biosystems Nominated for Two TechPoint Mira Awards for Technology Excellence and Innovation
8. TriLink BioTechnologies Awards Keck Science Department ResearchReward
9. Young Pathologists Receive Awards for Research
10. National Non-Profit Awards Audio Conferencing to SoundConnect
11. Brain Research Foundation 2013 Scientific Innovations Awards To Dr. Jean Hebert and Dr. Brian Litt
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/28/2017)... ... February 28, 2017 , ... Surface Plasmon Resonance (SPR) is ... optical phenomenon that is sensitive to changes in the dielectric properties of the medium ... changes in refractive index occurring up to 300 nm above the metal surface (Au) ...
(Date:2/28/2017)... 2017  Phosphorus, a computational genomics and clinical ... the Phosphorus Scientific Advisory Board, an established group ... the company on the development of new products ... visit http://phosphorus.com/about-us/ to learn more about ... gathered some of the top leaders in the ...
(Date:2/28/2017)... 28, 2017  Xencor, Inc. (NASDAQ: XNCR), a clinical-stage ... treatment of autoimmune diseases, asthma and allergic diseases ... fourth quarter and full year ended December 31, ... recent business and clinical highlights. "During ... development pipeline by starting five clinical trials across ...
(Date:2/28/2017)... MA (PRWEB) , ... February 28, 2017 , ... ... clinical trials, yet requires extensive coordination and expertise. Colpitts Clinical Trial Travel ... celebrating 15 years of meeting this unique need within the biotechnology and pharmaceutical ...
Breaking Biology Technology:
(Date:2/21/2017)... February 21, 2017 Der weltweite ... wachsen. Nach einem Gespräch mit mehr als 50 Vertretern aus ... zu überwinden gilt, um diese Prognose zu realisieren. ... ... Mobilisierung der finanziellen Mittel für die Biobank, die Implementierung ...
(Date:2/13/2017)... 2017 Former 9/11 Commission border counsel and ... Janice Kephart of Identity Strategy Partners, LLP, today ... "Executive Order: Protecting the Nation From Foreign Terrorist ... "As President Trump,s ,Travel Ban, Executive Order gains ... banned the travel ban, it is important that our ...
(Date:2/8/2017)... 7, 2017  Aware, Inc. (NASDAQ: AWRE ), ... financial results for its quarter and year ended December 31, ... 2016 was $3.9 million compared to $6.9 million in the ... of 2016 was $0.6 million compared to $2.6 million in ... quarter of 2016 was $0.5 million, or $0.02 per diluted ...
Breaking Biology News(10 mins):